By combining insight from fundamental and industrial research we can provide the link between raw materials, manufacturing processes and the needs of the patient. This spans all unit operations, processes and operation procedures during the manufacture of medicines in relation to their impact upstream on the efficiency of product and process design and downstream on product performance. Our objective is to improve quality systems, real time release/performance, materials properties, particle attributes, surface chemistry, formulation, processing ‘rules’, and the Manufacturing Classification System.
WP4 is led and predominantly delivered by the University of Leeds, but also calls on specialist expertise from other partners, such as PSE for..., and the University of Cambridge and CCDC with regard to how fundamental bulk and surface properties of crystalline structures can be linked to bulk material properties.